ClinicalTrials.gov
ClinicalTrials.gov Menu

Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00615043
Recruitment Status : Completed
First Posted : February 14, 2008
Last Update Posted : December 22, 2010
Sponsor:
Information provided by:
Tengion

Brief Summary:
The objective of the study is to obtain bladder tissue specimens from patients otherwise undergoing cystoscopy for use in research at Tengion, Inc.

Condition or disease Intervention/treatment
Bladder Disease Procedure: Bladder biopsy

Study Type : Observational
Actual Enrollment : 6 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Multi Center Study to Obtain Bladder Tissue Specimens From Subjects Undergoing Transurethral Resection of Bladder Tumor (TURBT) or Other Transurethral Biopsy Procedures
Study Start Date : February 2008
Actual Primary Completion Date : September 2008
Actual Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
TURBT group
Subjects undergoing transurethral resection of bladder tumor or other transurethral biopsy procedure who agree to provide bladder tissue specimens
Procedure: Bladder biopsy
provision of bladder tissue via cystoscopic biopsy during planned TURBT



Primary Outcome Measures :
  1. Evaluation of bladder tissue from patients undergoing transurethral resection of bladder tumor or other transurethral biopsy procedure [ Time Frame: ongoing throughout study ]

Biospecimen Retention:   Samples Without DNA
Tissue


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients otherwise undergoing TURBT
Criteria

Inclusion Criteria:

  • Subjects 18-90 years and undergoing TURBT
  • Willing and able to give signed informed consent

Exclusion Criteria:

  • Known active infection
  • Known colonization with MRSA or VRE
  • Receipt of blood or blood products for transfusion during the previous 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00615043


Locations
United States, Alabama
University of Alabama, Birmingham
Birmingham, Alabama, United States, 35233
Sponsors and Collaborators
Tengion
Investigators
Study Director: Sunita Sheth, MD Tengion, Inc

Responsible Party: Sunita Sheth, MD Chief Medical Officer, Tengion, Inc
ClinicalTrials.gov Identifier: NCT00615043     History of Changes
Other Study ID Numbers: TNG-CL007
First Posted: February 14, 2008    Key Record Dates
Last Update Posted: December 22, 2010
Last Verified: December 2010

Keywords provided by Tengion:
Transurethral resection of bladder tumor
TURBT

Additional relevant MeSH terms:
Urinary Bladder Diseases
Urologic Diseases